Trials / Completed
CompletedNCT00645164
Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- Healthpoint · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The product is being tested to see if exposure to light causes photoallergic reactions on the skin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Ointment Vehicle | Subject acts as own control. 20 mg under Finn chambers |
| DRUG | Xenaderm | 20 mg under Finn chambers |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2008-05-01
- Completion
- 2008-06-01
- First posted
- 2008-03-27
- Last updated
- 2010-06-08
- Results posted
- 2009-04-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00645164. Inclusion in this directory is not an endorsement.